Paula Ragan Sells 6,292 Shares of X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Stock

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Get Rating) CEO Paula Ragan sold 6,292 shares of the firm’s stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $1.95, for a total transaction of $12,269.40. Following the completion of the transaction, the chief executive officer now directly owns 557,245 shares […]

Related Keywords

Stifel Nicolaus ,Paula Ragan ,York Mellon Corp ,Securities Exchange Commission ,Nasdaq ,Virtu Financial ,Pharmaceuticals Company Profile ,Connor Clark Lunn Investment Management Ltd ,Cantor Fitzgerald ,Renaissance Technologies ,Pharmaceuticals Inc ,Pharmaceuticals Daily ,Pharmaceuticals Stock Performance ,Get Rating ,Exchange Commission ,New York Mellon Corp ,Street Group ,Connor Clark ,Lunn Investment Management ,X4 Pharmaceuticals ,Nasdaq Xfor ,Wexfor ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,